Zai Lab

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Zai Lab and other ETFs, options, and stocks.

About ZLAB

Zai Lab Ltd. is a biopharmaceutical company, which engages in the developing and commercializing therapies that address medical conditions with unmet needs in oncology, autoimmune disorders, infectious diseases, and neuroscience. Its products include Zejula, Optune, Qinlock, and Nuzyra.

CEO

Ying Du

CEOYing Du

Employees

1,869

Employees1,869

Headquarters

Shanghai, Shanghai

HeadquartersShanghai, Shanghai

Founded

2014

Founded2014

Employees

1,869

Employees1,869

ZLAB Key Statistics

Market cap

3.53B

Market cap3.53B

Price-Earnings ratio

-15.03

Price-Earnings ratio-15.03

Dividend yield

—

Dividend yield—

Average volume

607.76K

Average volume607.76K

High today

$32.11

High today$32.11

Low today

$30.77

Low today$30.77

Open price

$31.95

Open price$31.95

Volume

1.41M

Volume1.41M

52 Week high

$44.34

52 Week high$44.34

52 Week low

$19.16

52 Week low$19.16

ZLAB News

Seeking Alpha 5d

Amgen dips after trial update for Zai Lab partnered gastric cancer therapy

Amgen (NASDAQ:AMGN) stock dipped on Wednesday following an update from its partner, Zai Lab (NASDAQ:ZLAB), regarding the late-stage trial of bemarituzumab combi...

TipRanks 5d

Zai Lab to wait on results of FORTITUDE-102 prior to regulatory filing

The following announcement was made by Zai Lab (ZLAB) pursuant to Rule 13.09(2)(a) of the Rules Governing the Listing of Securities on The Stock Exchange of Hon...

TipRanks 7d

Zai Lab announces approval of TIVDAK in Hong Kong

Zai Lab (ZLAB) announced the Hong Kong Department of Health has approved TIVDAK in Hong Kong for the treatment of adult patients with recurrent or metastatic ce...

Analyst ratings

86%

of 14 ratings

Buy

85.7%

Hold

14.3%

Sell